Cargando…

CNS Invasion in Meningioma—How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence

SIMPLE SUMMARY: Brain invasion has been integrated into the new WHO classification of meningiomas to improve the prognostic assessment regarding tumor recurrence. However, its role has been questioned. One of the reasons is that for complete histopathological assessment, tissue sampling of the compl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behling, Felix, Fodi, Christina, Gepfner-Tuma, Irina, Machetanz, Kathrin, Renovanz, Mirjam, Skardelly, Marco, Bornemann, Antje, Honegger, Jürgen, Tabatabai, Ghazaleh, Tatagiba, Marcos, Schittenhelm, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761660/ https://www.ncbi.nlm.nih.gov/pubmed/33287241 http://dx.doi.org/10.3390/cancers12123620

Ejemplares similares

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
por: Behling, Felix, et al.
Publicado: (2020)

Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
por: Behling, Felix, et al.
Publicado: (2021)

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
por: Behling, Felix, et al.
Publicado: (2020)

Increased proliferation is associated with CNS invasion in meningiomas
por: Behling, Felix, et al.
Publicado: (2021)

The prognostic role of the immunohistochemical expression of S100 in meningiomas
por: Behling, Felix, et al.
Publicado: (2022)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
por: Fodi, Christina, et al.
Publicado: (2021)

Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
por: Fodi, Christina, et al.
Publicado: (2022)

COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake
por: Behling, Felix, et al.
Publicado: (2019)

Integrative assessment of brain and bone invasion in meningioma patients
por: Zwirner, Kerstin, et al.
Publicado: (2019)

Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2?
por: Behling, Felix, et al.
Publicado: (2023)

The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
por: Fodi, Christina-Katharina, et al.
Publicado: (2022)

A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized Trials
por: Skardelly, Marco, et al.
Publicado: (2021)

Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort
por: Gonçalves, Vítor Moura, et al.
Publicado: (2021)

Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13, 466
por: Gonçalves, Vítor Moura, et al.
Publicado: (2023)

Differences in intraoperative sampling during meningioma surgery regarding CNS invasion – Results of a survey on behalf of the EANS skull base section
por: Behling, Felix, et al.
Publicado: (2023)

Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
por: Hoffmann, Elgin, et al.
Publicado: (2021)

COX2 expression is associated with preoperative tumor volume but not with volumetric tumor growth in vestibular schwannoma
por: Behling, Felix, et al.
Publicado: (2021)

Depatux-M and temozolomide in advanced high-grade glioma
por: Hirsch, Sophie, et al.
Publicado: (2020)

Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival
por: Behling, Felix, et al.
Publicado: (2022)

PAX6 is frequently expressed in ependymal tumours and associated with prognostic relevant subgroups
por: Tabasaran, Julian, et al.
Publicado: (2022)

Tumortherapieassoziierte neurologische Symptome
por: Renovanz, Mirjam, et al.
Publicado: (2021)

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors
por: Engelhardt, Sophie, et al.
Publicado: (2022)

COMPREHENSIVE MULTIPLATFORM ANALYSIS OF CDKN2A ALTERATIONS IN MENINGIOMAS
por: Wang, Justin Z, et al.
Publicado: (2023)

ATRX immunostaining predicts IDH and H3F3A status in gliomas
por: Ebrahimi, Azadeh, et al.
Publicado: (2016)

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Brain Invasion in Meningioma—A Prognostic Potential Worth Exploring
por: Behling, Felix, et al.
Publicado: (2021)

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
por: Behling, Felix, et al.
Publicado: (2016)

Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment
por: Trautwein, Christoph, et al.
Publicado: (2022)

Robot‐assisted stereoencephalography vs subdural electrodes in the evaluation of temporal lobe epilepsy
por: Gorbachuk, Mykola, et al.
Publicado: (2023)

Correction to: Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes
por: Brendle, Cornelia, et al.
Publicado: (2021)

Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes
por: Brendle, Cornelia, et al.
Publicado: (2020)

Impact of (18)F-FET PET/MRI on Clinical Management of Brain Tumor Patients
por: Brendle, Cornelia, et al.
Publicado: (2022)

Sex Differences in Vestibular Schwannoma
por: Machetanz, Kathrin, et al.
Publicado: (2023)

Trading mental and physical health in vestibular schwannoma treatment decision
por: Machetanz, Kathrin, et al.
Publicado: (2023)

Meningiomas with CNS invasion
por: Gousias, Konstantinos, et al.
Publicado: (2023)

Transition of a vestibular schwannoma to a malignant peripheral nerve sheath tumor with loss of H3K27 trimethylation after radiosurgery—a case report and review of the literature
por: Behling, Felix, et al.
Publicado: (2021)

Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale – a bicentric retrospective study
por: Barz, Melanie, et al.
Publicado: (2021)

Association of extent of resection on recurrence-free survival and functional outcome in vestibular schwannoma of the elderly
por: Wang, Sophie Shih-Yüng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mp0glah3ig4rifs5ea5fhdoiut